HR Execs on the Move

U V Iii Systems

www.uv3.com

 
U V Iii Systems is a Bellingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.uv3.com

  • Bellingham, MA USA 02019
  • Phone: 508.883.4881

Executives

Name Title Contact Details

Similar Companies

HealthRisk Resource Group

HealthRisk Resource Group is a Orange, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amber Diagnostics

Amber Diagnostics is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jack Nathan Health

At Jack Nathan Health, we are committed to improving access to public health care to over 1.1 million patients per-year by delivering consistent, quality care in state-of-the-art medical and dental clinics in Walmart stores across Canada. Jack Nathan Health is proud to partner with Walmart Canada to deliver quality health care services and convenience to its customers. Walmart currently operates over 390 stores and serves more than 1 million customers each day across Canada. They are the third largest employer in Canada with more than 90,000 associates and offer a full range of groceries, general merchandise and specialty services - including Medical & Dental Clinics - under one roof.

TherOx

TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.

Phoenix Data Systems

Phoenix Data Systems, Inc. is a King Of Prussia, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.